These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6972966)

  • 41. A simple method for the quantitation of specific cytotoxic precursors to syngeneic tumors.
    Teh HS; Kwong L; Yu M; Kilburn DG
    J Immunol Methods; 1981; 46(1):97-111. PubMed ID: 7026690
    [No Abstract]   [Full Text] [Related]  

  • 42. Functional studies of the products of H-2L locus.
    Levy RB; Hansen TH
    Immunogenetics; 1980; 10(1):7-17. PubMed ID: 6967857
    [No Abstract]   [Full Text] [Related]  

  • 43. Recognition of conformational determinants on H-2 by cytolytic T lymphocytes.
    Sherman LA
    Nature; 1982 Jun; 297(5866):511-3. PubMed ID: 6178030
    [No Abstract]   [Full Text] [Related]  

  • 44. Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse.
    Fujimoto S; Matsuzawa T; Nakagawa K; Tada T
    Cell Immunol; 1978 Jul; 38(2):378-87. PubMed ID: 307988
    [No Abstract]   [Full Text] [Related]  

  • 45. H-2-linked genetic control of murine cell-mediated lympholysis to autologous cells modified with high and low concentrations of fluorescein isothiocyanate.
    Gilheany P; Arora PK; Levy RB; Shearer GM
    Cell Immunol; 1981 Mar; 59(1):97-105. PubMed ID: 7214547
    [No Abstract]   [Full Text] [Related]  

  • 46. Search for the physiological function of H-2 gene products.
    Lengerová A; Zelený V; Haskovec C; Hilgert I
    Eur J Immunol; 1977 Feb; 7(2):62-9. PubMed ID: 872865
    [No Abstract]   [Full Text] [Related]  

  • 47. The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment.
    Bennink JR; Doherty PC
    Cell Immunol; 1981 Jun; 61(1):220-4. PubMed ID: 6973400
    [No Abstract]   [Full Text] [Related]  

  • 48. Presence in unprimed mice of helper T cells specific for antigens closely related to self and their possible relevance to tumor immunology.
    Pilarski LM; McKenzie IF
    Cell Immunol; 1981 Jan; 57(2):316-26. PubMed ID: 6971162
    [No Abstract]   [Full Text] [Related]  

  • 49. H-2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets.
    Stutman O; Shen FW
    Nature; 1978 Nov; 276(5684):181-2. PubMed ID: 216918
    [No Abstract]   [Full Text] [Related]  

  • 50. Established murine cytolytic T-cell lines as tools for a somatic cell genetic analysis of T-cell functions.
    Nabholz M; Conzelmann A; Acuto O; North M; Haas W; Pohlit H; von Boehmer H; Hengartner H; Mach JP; Engers H; Johnson JP
    Immunol Rev; 1980; 51():125-56. PubMed ID: 6159300
    [No Abstract]   [Full Text] [Related]  

  • 51. Allogeneic cytolysis of reconstituted membrane vesicles.
    Hollander N; Mehdi SQ; Weissman IL; McConnell HM; Kriss JP
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4042-5. PubMed ID: 315069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T-cell inhibition of humoral responsiveness. II. Theory on the role of restrictive recognition in immune regulation.
    Cohn M; Epstein R
    Cell Immunol; 1978 Aug; 39(1):125-53. PubMed ID: 308845
    [No Abstract]   [Full Text] [Related]  

  • 53. Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors.
    Kruse CA; Schiltz PM; Bellgrau D; Kong Q; Kleinschmidt-DeMasters BK
    J Neurooncol; 1994; 19(2):161-8. PubMed ID: 7964992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.
    Bahler DW; Frelinger JG; Harwell LW; Lord EM
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4562-6. PubMed ID: 3496596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 57. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MHC-coded unique alloantigens and antitumor immunity.
    Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
    [No Abstract]   [Full Text] [Related]  

  • 59. Quantitative appraisal of H-2 products in T cell-mediated lysis by allogeneic and syngeneic effector cells.
    Kuppers RC; Ballas ZK; Green WR; Henney CS
    J Immunol; 1981 Aug; 127(2):500-4. PubMed ID: 6972966
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.